An older doctor sits in front of screens showing diagnostic imaging

五月 17, 2018

Philips invests $10 million in Cardeation Capital to combat heart disease

Estimated reading time: 1 minute

Share on social media

  • 鏈接已復制


Nick Pappas

Nick Pappas

Managing Partner, Venture Investments

New venture capital fund focuses on improving care for heart disease and stroke


Rates of cardiovascular disease are rising and costs are approaching $1 trillion annually in the United States. To ensure that effective innovations are rapidly introduced into the healthcare system, Philips, the American Heart Association and UPMC have partnered to create the $30 million Cardeation Capital venture capital fund.


The new fund will invest in emerging healthcare companies that can measurably affect the prevention and treatment of cardiovascular diseases and stroke — and their risk factors, such as diabetes. Cardeation Capital’s investors will fund best-in-class technology companies with scalable products and services that address healthcare delivery and health management.

Related insights

Want to become a start-up partner with Philips Ventures?

Changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


使用最新版 Microsoft Edge、Google Chrome 或 Firefox 瀏覽本網站效果最佳。